About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
https://www.soho2019.com/
Hodgkin Lymphoma
Multiple Myeloma
Chronic Lymphocytic Leukemia
Meet The Professor Sessions
Chronic Myeloid Leukemia
Myeloproliferative Neoplasms
Breakfast With The Expert
Independent Satellite Symposium
Plenary Sessions
Evolving Practices in AML: A Case-based Guide to New and Emerging Treatment Options
Acute Lymphoblastic Leukemia
Myelodysplastic Syndromes
Acute Myeloid Leukemia
Indolent B-cell Lymphoma
Mantle Cell Lymphoma
Aggressive B-cell Lymphoma
T-cell Lymphoma
Cellular Therapy
Next Questions
Events
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
E
Next Questions in AML: Incorporation of New Therapies, Which Patients Should Receive Venetoclax and How, Is MRD Replacing Marrow Morphology, Origin of AML?
By
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
FEATURING
Eunice Wang
By
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
FEATURING
Eunice Wang
112 views
October 18, 2019
0 Comments
Login to view comments.
Click here to Login
Featured Video
06:51
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…
Feat.
D. Tremblay
Featured Video
15:14
Icahn School of Medicine at Mount Sinai
Safety Profile of Ruxolitinib in Patients With MF
Feat.
D. Tremblay
Next Questions
11:45
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
Next Questions in ALL: Non-Chemo Regimes, The Use of Bcl2-Bclxl Inhi…
Feat.
H. Kantarjian
10:56
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
Next Questions in AML: Incorporation of New Therapies, Which Patient…
Feat.
E. Wang
09:48
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
Automated and Decentralized CAR-T Cell Manufacture: Enabling Local M…
Feat.
B. Dropulic
07:40
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
CLL Next Questions: How To Achieve Undetectable MRD & Cure More …
Feat.
W. Wierda
27:31
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
Moving Next-Generation TKIs Into Earlier Lines of Therapy - How I Tr…
Feat.
E. Jabbour
07:09
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
Next Questions in DLBCL: New Genetic Classification Based Selection …
Feat.
A. Younes
10:49
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
Follicular Lymphoma - Next Steps: What is the First-Line Standard in…
Feat.
R. Marcus
10:18
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
Next Qs in Peripheral T-Cell Lymphoma: the Advancement of Care, Impa…
Feat.
O. O’Connor
08:13
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
Next Questions in Mantle Cell Lymphoma: Do We Need Chemo at All; Is …
Feat.
S. Rule
08:39
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
Next Questions in Hodgkin Lymphoma: Brentuximab Vedotin/PD-1+AVD as …
Feat.
S. Ansell
10:18
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
Next Questions in Myelodysplastic Syndromes: New Approaches for Anem…
Feat.
G. Garcia-Manero
12:02
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
Next Questions in Myeloproliferative Neoplasms: What Antibody Format…
Feat.
S. Verstovsek
